Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelsey B Bennion

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
JCI Insight|June 9, 2025
CD154:CD11b blockade enhances CD8+ T cell differentiation during infection but not transplantationKatie L Alexander, Kelsey B Bennion, Danya Liu, et al.
JCI Insight|March 24, 2025
Macrophage-derived Fgl2 dampens antitumor immunity through regulation of FcγRIIB+CD8+ T cells in melanomaKelsey B Bennion, Julia Miranda R Bazzano, Danya Liu, et al.
Experimental Cell Research|April 4, 2021
Overexpression and surface localization of HPRT in prostate cancer provides a potential target for cancer specific antibody mediated cellular cytotoxicityMichelle H Townsend, Kelsey B Bennion, Eliza E Bitter, et al.
JCI Insight|February 22, 2021
FcγRIIB is a T cell checkpoint in antitumor immunityClara R Farley, Anna B Morris, Marvi Tariq, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 2021
Tumor-Specific T Cells Exacerbate Mortality and Immune Dysregulation during SepsisChing-Wen Chen, Kelsey B Bennion, David A Swift, et al.
Nature Communications|June 20, 2024
CD8<sup>+</sup> T cell-derived Fgl2 regulates immunity in a cell-autonomous manner via ligation of FcγRIIBKelsey B Bennion, Danya Liu, Abdelhameed S Dawood, et al.
Science Translational Medicine|August 23, 2023
FcγRIIB expressed on CD8<sup>+</sup> T cells limits responsiveness to PD-1 checkpoint inhibition in cancerKelsey B Bennion, Marvi Tariq, Megan M Wyatt, et al.
JCI Insight|April 8, 2025
Fgl2 regulates FcγRIIB+CD8+ T cell responses during infectionAnna B Morris, Max W Adelman, Kelsey B Bennion, et al.
JCI Insight|May 22, 2026
Broadening activity of checkpoint blockade agents by intratumoral nucleoside cleavageRegina Rab, Jeong S Hong, Brendan Lc Kinney, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
JCI Insight|June 9, 2025
CD154:CD11b blockade enhances CD8+ T cell differentiation during infection but not transplantationKatie L Alexander, Kelsey B Bennion, Danya Liu, et al.
JCI Insight|March 24, 2025
Macrophage-derived Fgl2 dampens antitumor immunity through regulation of FcγRIIB+CD8+ T cells in melanomaKelsey B Bennion, Julia Miranda R Bazzano, Danya Liu, et al.
Experimental Cell Research|April 4, 2021
Overexpression and surface localization of HPRT in prostate cancer provides a potential target for cancer specific antibody mediated cellular cytotoxicityMichelle H Townsend, Kelsey B Bennion, Eliza E Bitter, et al.
JCI Insight|February 22, 2021
FcγRIIB is a T cell checkpoint in antitumor immunityClara R Farley, Anna B Morris, Marvi Tariq, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 2021
Tumor-Specific T Cells Exacerbate Mortality and Immune Dysregulation during SepsisChing-Wen Chen, Kelsey B Bennion, David A Swift, et al.
Nature Communications|June 20, 2024
CD8<sup>+</sup> T cell-derived Fgl2 regulates immunity in a cell-autonomous manner via ligation of FcγRIIBKelsey B Bennion, Danya Liu, Abdelhameed S Dawood, et al.
Science Translational Medicine|August 23, 2023
FcγRIIB expressed on CD8<sup>+</sup> T cells limits responsiveness to PD-1 checkpoint inhibition in cancerKelsey B Bennion, Marvi Tariq, Megan M Wyatt, et al.
JCI Insight|April 8, 2025
Fgl2 regulates FcγRIIB+CD8+ T cell responses during infectionAnna B Morris, Max W Adelman, Kelsey B Bennion, et al.
JCI Insight|May 22, 2026
Broadening activity of checkpoint blockade agents by intratumoral nucleoside cleavageRegina Rab, Jeong S Hong, Brendan Lc Kinney, et al.
Pageof 1